Clinical Trials in Philadelphia

Showing 17501-17520 of 20,904 trials

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

NCT00068770

RATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. It is not yet known whether the effectiveness of celecoxib in treating glioblastoma multiforme is decreased in patients who are receiving anticonvulsant drugs and undergoing radiation therapy. PURPOSE: Phase II trial to study the effectiveness of celecoxib in treating patients who are receiving anticonvulsant drugs and undergoing radiation therapy for newly diagnosed glioblastoma multiforme.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted Oct 2003

Tampa, Florida, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +4 more locations

COMPLETEDPhase 1< 1 mile

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

NCT00320775

The purpose of this trial is to assess the ocular and systemic safety and tolerability of a single intravitreal injection of VEGF Trap in patients with subfoveal choroidal neovascularization (CNV) due to AMD.

Macular Degeneration

Regeneron Pharmaceuticals51 participantsStarted Jun 2005

Tuscon, Arizona, United States • Loma Linda, California, United States • Chicago, Illinois, United States +5 more locations

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Find Trials by Condition in Philadelphia

Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates

Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Urine Sample Collection From FOP Patients

Pharmacokinetics and Pharmacdynamics of Sildenafil

Evaluating a Website for Parents of Injured Children

Philadelphia Preterm Prevention Project

NVA237 BID Versus Placebo Twelve-week Efficacy Study

TeleQuit Smoking Cessation Program

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

Clinical Investigation of Expanded Designs of a Multifocal IOL

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

Identification and Validation of Biomarkers of Acute Kidney Injury Recovery

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Patient-Reported Outcomes in Adults With Congenital Heart Disease

Fibroid Ablation Study - Large Fibroids